TOKAI PHARMACEUTICALS INC's ticker is TKAI and the CUSIP is 88907J107. A total of 52 filers reported holding TOKAI PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2016 | $34,000 | -33.3% | 35,195 | +4.8% | 0.00% | – |
Q3 2016 | $51,000 | -72.6% | 33,588 | -0.5% | 0.00% | – |
Q2 2016 | $186,000 | -5.6% | 33,761 | -3.7% | 0.00% | – |
Q1 2016 | $197,000 | -35.0% | 35,054 | +0.7% | 0.00% | – |
Q4 2015 | $303,000 | -15.6% | 34,804 | +0.3% | 0.00% | – |
Q3 2015 | $359,000 | -22.8% | 34,683 | -0.9% | 0.00% | -100.0% |
Q2 2015 | $465,000 | +131.3% | 34,988 | +96.8% | 0.00% | – |
Q1 2015 | $201,000 | -13.7% | 17,778 | +12.3% | 0.00% | – |
Q4 2014 | $233,000 | – | 15,828 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Green Owl Capital Management, LLC | 130,000 | $1,729,000 | 1.23% |
Novo Holdings A/S | 1,238,252 | $16,469,000 | 1.18% |
Perceptive Advisors | 485,338 | $6,455,000 | 0.39% |
KINGDON CAPITAL MANAGEMENT, L.L.C. | 740,978 | $9,855,000 | 0.38% |
Tourbillon Capital Partners, L.P. | 517,000 | $6,876,000 | 0.15% |
SABBY MANAGEMENT, LLC | 128,041 | $1,703,000 | 0.06% |
Alyeska Investment Group, L.P. | 613,134 | $8,154,000 | 0.05% |
ROPES WEALTH ADVISORS LLC | 6,000 | $80,000 | 0.04% |
OPPENHEIMER & CO INC | 12,048 | $160,000 | 0.00% |
FRANKLIN RESOURCES INC | 451,700 | $6,008,000 | 0.00% |